Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
13 January 2015 |
Main ID: |
ISRCTN19338940 |
Date of registration:
|
20/12/2005 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Can we introduce evidence based prescribing of complementary drug therapies into primary care? A randomised controlled trial.
|
Scientific title:
|
|
Date of first enrolment:
|
26/06/2004 |
Target sample size:
|
55 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN19338940 |
Study type:
|
Interventional |
Study design:
|
Cluster randomised controlled trial (Treatment)
|
Phase:
|
|
|
Countries of recruitment
|
United Kingdom
| | | | | | | |
Contacts
|
Name:
|
Maria Paola
Dey |
Address:
|
Department of Public Health
Bury Primary Care Trust
21 Silver Street
BL9 0EN
Bury
United Kingdom |
Telephone:
|
|
Email:
|
MPDey@uclan.ac.uk |
Affiliation:
|
|
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: General practitioners in Bury PCT
Exclusion criteria: General practitioners on the local medicines management subgroup and the other GPs in their practices
Age minimum:
Age maximum:
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Osteoarthritis Musculoskeletal Diseases Gonarthrosis
|
Intervention(s)
|
Dissemination of a recommendation for the prescribing of glucosamine for knee osteoarthritis endosed by the Bury PCT Medicines Management Subgroup and accompanied by a letter of support signed by the Director of Public Health, Bury PCT.
|
Primary Outcome(s)
|
Change in the mean number of prescriptions for glucosamine sulphate 500 mg per general practitioner over study period.
|
Secondary Outcome(s)
|
1. Change in cost to the NHS of prescriptions for glucosamine per general practitioner over study period 2. Proportion of GP prescribing glucosamine sulphate 500 mg during study period 3. If sufficient change in prescribing observed, number of admissions for gastrointestinal bleeding 4. Change in mean number of prescriptions of NSAID and COX2
|
Source(s) of Monetary Support
|
Bury Primary Care Trust (UK)
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|